1. In hepatocellular carcinoma miR-494 up-regulates the AKT/mTOR pathway and is involved in Sorafenib resistance. (10th February 2016) Authors: Pollutri, D.; Patrizi, C.; Marinelli, S.; Ferracin, M.; Negrini, M.; Toaldo, M. Baron; Bolondi, L.; Gramantieri, L.; Fornari, F. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MiR-122 targets SerpinB3 and is involved in Sorafenib resistance in hepatocellular carcinoma. Issue 1 (16th February 2017) Authors: Pollutri, D.; Fornari, F.; Turato, C.; Villano, G.; Quarta, S.; Ruvoletto, M.; Bolondi, L.; Gramantieri, L.; Pontisso, P. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗